Key Takeaways
- • Vivo Capital appoints Neetesh Kumar as managing partner to co-lead US private equity and buyout operations, with a mandate to establish the firm's New York presence and expand its buyout strategy.
- • Kumar brings over 30 years of experience across private equity, growth equity, venture capital, and credit, most recently from Spruceview Capital Partners where he oversaw $4 billion in assets.
- • Vivo Capital, founded in 1996, manages approximately $7 billion across venture capital, growth equity, buyout, and public equity strategies focused on healthcare, with portfolio of 460+ companies.
- • Kumar's appointment reflects Vivo Capital's strategic focus on the convergence of healthcare and technology, positioning the firm to capitalize on digital transformation within the healthcare sector.
- • Kumar's career trajectory includes senior roles at J.P. Morgan Chase retirement plan, UC Investments, One Equity, and early-stage technology experience at Andersen Consulting and as a founding team member of Vetri Systems.
Summary
Vivo Capital, a global healthcare-focused investment firm, has recruited Neetesh Kumar as a managing partner to co-lead its US private equity and buyout platform and establish the firm's New York office. The appointment signals the healthcare specialist's expansion ambitions in the buyout space and reflects broader market demand for experienced private markets operators with deep sector expertise.
Kumar joins Vivo Capital from Spruceview Capital Partners, where he held the title of partner and adviser managing more than $4 billion in assets. His track record spans three decades across private equity, growth equity, venture capital, and credit markets. His career includes senior investment positions at J.P. Morgan Chase's retirement plan division, UC Investments, Rho Fund Investors, and One Equity Partners, demonstrating sustained exposure to institutional capital deployment and large-scale portfolio management. Kumar also spent time at Banc One Capital Partners and began his career in technology at Andersen Consulting, where he contributed to early-stage software initiatives and served as a founding team member of Vetri Systems.
Vivo Capital, headquartered in Palo Alto and founded in 1996, operates as a comprehensive healthcare investor managing approximately $7 billion across multiple strategies—venture capital, growth equity, buyout, and public equity. The firm has deployed capital across more than 460 companies and maintains a team of over 70 professionals across its California base and Asian offices. Co-founder and managing partner Frank Kung emphasized that Kumar's deep private markets experience will accelerate Vivo Capital's buyout strategy development.
Kumar highlighted the healthcare-technology convergence as a primary source of opportunity driving his decision to join Vivo Capital. This positioning aligns with broader industry trends toward digital health, artificial intelligence integration in clinical workflows, and technology-enabled healthcare service delivery—areas where buyout firms have increasingly focused capital in recent years. The appointment positions Vivo Capital to compete more aggressively in the mid-market to lower-middle-market buyout segment within healthcare and adjacent sectors.
Kumar joins Vivo Capital from Spruceview Capital Partners, where he held the title of partner and adviser managing more than $4 billion in assets. His track record spans three decades across private equity, growth equity, venture capital, and credit markets. His career includes senior investment positions at J.P. Morgan Chase's retirement plan division, UC Investments, Rho Fund Investors, and One Equity Partners, demonstrating sustained exposure to institutional capital deployment and large-scale portfolio management. Kumar also spent time at Banc One Capital Partners and began his career in technology at Andersen Consulting, where he contributed to early-stage software initiatives and served as a founding team member of Vetri Systems.
Vivo Capital, headquartered in Palo Alto and founded in 1996, operates as a comprehensive healthcare investor managing approximately $7 billion across multiple strategies—venture capital, growth equity, buyout, and public equity. The firm has deployed capital across more than 460 companies and maintains a team of over 70 professionals across its California base and Asian offices. Co-founder and managing partner Frank Kung emphasized that Kumar's deep private markets experience will accelerate Vivo Capital's buyout strategy development.
Kumar highlighted the healthcare-technology convergence as a primary source of opportunity driving his decision to join Vivo Capital. This positioning aligns with broader industry trends toward digital health, artificial intelligence integration in clinical workflows, and technology-enabled healthcare service delivery—areas where buyout firms have increasingly focused capital in recent years. The appointment positions Vivo Capital to compete more aggressively in the mid-market to lower-middle-market buyout segment within healthcare and adjacent sectors.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.